Delivery Order SPE2DB24D2100-SPE2DB24FBDGW

Award Date 8/29/24
Potential Completion Date 9/20/24
Potential Value $21K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Afinitor 10 mg tablets. The contract has a firm fixed price of $12,360.81 and a completion date of January 28, 2025. The award is not associated with a set-aside program, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
This is a delivery order contract awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of Afinitor 10 mg tablets, a specialty pharmaceutical product. The contract has a ceiling value of $41,610.64 and an ultimate completion date of October 21, 2024. This award is not associated with a set-aside program. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to various government agencies,...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Afinitor Disperz 5 mg tablets, a specialty medication. The contract has a ceiling value of $12,333.53 and a completion date of February 14, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
This is a $12,352.52 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of AFINITOR 5 MG TABLET UD 28S, a prescription medication, with a period of performance through June 2025. Amerisourcebergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a wide range of...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Afinitor Disperz 5 mg tablets, a pharmaceutical product, with a ceiling value of $37,000.59. The contract is a firm fixed-price delivery order, without a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a for-profit organization...
This is a federal contract award from the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $35,747.88, to provide AFINITOR DISPERZ 3 MG TABLET 28S. The contract has an ultimate completion date of June 18, 2025. Amerisourcebergen Drug Corp also holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The firm fixed price contract is for the supply of Afinitor 10 mg tablets, with a potential value of $20,805.32. The contract is to be completed by February 1, 2024, with the award date being January 10, 2024. No set-aside was used for this award. Amerisourcebergen Drug Corp has previously...
This is a $10,447.08 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the supply of AFINITOR 7.5 MG TABLET UD 28S. The contract has an ultimate completion date of October 8, 2024. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, with numerous Indefinite Delivery Contracts (IDCs) with defense and civilian agencies. This specific award is not associated...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $20,112.96 firm fixed price delivery order is for the supply of the pharmaceutical product AFINITOR 2.5 MG TABLET UD 28S. The contract has a completion date of January 25, 2024 and was awarded on January 3, 2024. No set-aside designation was used. Amerisourcebergen Drug Corp is a prime contractor that has received...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 0.5 mg Everolimus tablets, with a ceiling value of $13,739.02 and a period of performance through June 16, 2025. The contract is a firm-fixed-price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite...
  • SPE2DB24D2100
    Indefinite Delivery Contract
  • SPE2DB24D2100-SPE2DB24FBDGW
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Afinitor 10 mg tablets. The contract has a ceiling value of $20,805.32 and a period of performance ending on September 20, 2024. The contract is a firm-fixed-price type, with no set-aside designation. This award is likely part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract aims to provide essential pharmaceutical products to federal healthcare providers, including military treatment facilities and veterans' hospitals, as part of the DLA's mission to support the medical needs of the U.S. armed forces and other government agencies.

Generated 11/28/24, 9:40 AM